Get Premium to unlock powerful stock data
NAS:CSTL (USA)  
Castle Biosciences Inc logo

Castle Biosciences Inc

$ 23.34 -0.97 (-3.99%) 10:09 PM EST
P/E:
At Loss
P/B:
1.56
Market Cap:
$ 612.93M
Enterprise V:
$ 337.30M
Volume:
157.76K
Avg Vol (2M):
375.50K
Volume:
157.76K
Market Cap $:
612.93M
PE Ratio:
At Loss
Avg Vol (2-Month):
375.50K
Enterprise Value $:
337.30M
PB Ratio:
1.56
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Castle Biosciences Inc
NAICS : 621511 SIC : 8071
505 S. Friendswood Drive, Suite 401, Friendswood, TX, USA, 77546
Description
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Name Current Vs Industry Vs History
Cash-To-Debt 39.07
Equity-to-Asset 0.89
Debt-to-Equity 0.02
Debt-to-EBITDA -0.14
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.34
Distress
Grey
Safe
Beneish M-Score 9.31
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 61.12
9-Day RSI 60.42
14-Day RSI 56.83
6-1 Month Momentum % -45.62
12-1 Month Momentum % -70.07

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.51
Quick Ratio 8.45
Cash Ratio 7.82
Days Inventory 43.56
Days Sales Outstanding 65.34
Days Payable 47.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -33.6

Financials (Next Earnings Date:2022-08-09 Est.)

CSTL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CSTL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 98.124
EPS (TTM) ($) -2.04
Beta 1.06
Volatility % 60.19
14-Day RSI 56.83
14-Day ATR ($) 1.65397
20-Day SMA ($) 20.4245
12-1 Month Momentum % -70.07
52-Week Range ($) 15.58 - 78.585
Shares Outstanding (Mil) 26.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Castle Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More